INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,224,178 | +28.9% | 14,345,512 | +7.7% | 0.01% | +28.6% |
| Q2 2023 | $281,063,732 | +23.4% | 13,320,556 | -0.3% | 0.01% | +16.7% |
| Q1 2023 | $227,844,452 | -12.6% | 13,363,311 | +2.5% | 0.01% | -14.3% |
| Q4 2022 | $260,555,805 | +6.5% | 13,040,831 | +14.9% | 0.01% | 0.0% |
| Q3 2022 | $244,564,000 | +10.3% | 11,353,970 | +0.9% | 0.01% | +16.7% |
| Q2 2022 | $221,803,000 | -15.0% | 11,247,644 | +1.3% | 0.01% | 0.0% |
| Q1 2022 | $260,819,000 | -13.9% | 11,098,706 | -0.2% | 0.01% | -14.3% |
| Q4 2021 | $302,920,000 | +1.5% | 11,120,430 | +2.7% | 0.01% | 0.0% |
| Q3 2021 | $298,346,000 | -1.5% | 10,833,201 | +1.8% | 0.01% | -12.5% |
| Q2 2021 | $303,004,000 | -8.1% | 10,646,706 | +9.9% | 0.01% | -11.1% |
| Q1 2021 | $329,888,000 | +5.8% | 9,685,525 | +3.4% | 0.01% | 0.0% |
| Q4 2020 | $311,698,000 | +5.8% | 9,363,127 | +2.2% | 0.01% | -10.0% |
| Q3 2020 | $294,559,000 | +13.8% | 9,164,927 | -2.5% | 0.01% | +11.1% |
| Q2 2020 | $258,786,000 | +91.3% | 9,396,749 | +11.4% | 0.01% | +50.0% |
| Q1 2020 | $135,248,000 | -30.7% | 8,437,161 | +3.2% | 0.01% | -14.3% |
| Q4 2019 | $195,244,000 | +35.4% | 8,176,076 | +0.0% | 0.01% | +40.0% |
| Q3 2019 | $144,183,000 | -29.4% | 8,173,609 | +2.4% | 0.01% | -37.5% |
| Q2 2019 | $204,287,000 | -0.8% | 7,979,937 | +12.6% | 0.01% | 0.0% |
| Q1 2019 | $205,929,000 | +125.9% | 7,083,890 | +1.9% | 0.01% | +100.0% |
| Q4 2018 | $91,175,000 | -33.7% | 6,949,384 | +2.2% | 0.00% | -20.0% |
| Q3 2018 | $137,551,000 | -12.5% | 6,802,706 | +2.3% | 0.01% | -28.6% |
| Q2 2018 | $157,238,000 | +8.6% | 6,648,576 | +3.4% | 0.01% | +16.7% |
| Q1 2018 | $144,764,000 | -26.4% | 6,428,289 | +1.9% | 0.01% | -33.3% |
| Q4 2017 | $196,604,000 | +35.0% | 6,305,495 | +35.1% | 0.01% | +28.6% |
| Q3 2017 | $145,646,000 | +121.7% | 4,666,662 | +21.9% | 0.01% | +133.3% |
| Q2 2017 | $65,687,000 | -0.8% | 3,827,881 | +1.2% | 0.00% | 0.0% |
| Q1 2017 | $66,214,000 | +38.7% | 3,781,483 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $47,734,000 | -5.7% | 3,607,951 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $50,596,000 | +50.4% | 3,484,557 | +2.1% | 0.00% | +50.0% |
| Q2 2016 | $33,640,000 | -18.4% | 3,411,733 | +4.8% | 0.00% | -33.3% |
| Q1 2016 | $41,228,000 | -29.1% | 3,253,947 | +1.5% | 0.00% | -25.0% |
| Q4 2015 | $58,177,000 | -46.9% | 3,205,364 | -45.7% | 0.00% | 0.0% |
| Q3 2015 | $109,588,000 | +131.3% | 5,901,414 | +204.2% | 0.00% | +33.3% |
| Q2 2015 | $47,381,000 | +45.5% | 1,940,220 | +23.9% | 0.00% | +50.0% |
| Q1 2015 | $32,567,000 | +58.6% | 1,565,733 | +18.0% | 0.00% | +100.0% |
| Q4 2014 | $20,533,000 | +32.7% | 1,327,233 | +11.9% | 0.00% | 0.0% |
| Q3 2014 | $15,474,000 | -22.0% | 1,185,742 | +19.4% | 0.00% | -50.0% |
| Q2 2014 | $19,841,000 | +10.9% | 993,045 | +5.7% | 0.00% | 0.0% |
| Q1 2014 | $17,892,000 | +23.1% | 939,654 | +10.0% | 0.00% | +100.0% |
| Q4 2013 | $14,537,000 | +18.7% | 854,605 | +8.9% | 0.00% | 0.0% |
| Q3 2013 | $12,245,000 | +54.4% | 784,438 | +18.3% | 0.00% | 0.0% |
| Q2 2013 | $7,932,000 | – | 663,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |